Expression of mRNA of tumor necrosis factor α and interleukin-6 in bullons pemphigoid skin

European Journal of Dermatology

Volumn 6, Issue 4, 1996, Pages 300-303

  Kuwabara, Hiroko ^a   McVittie, Eva ^a   Hunter, John A A ^a   Uda, Hirotsugu ^b   Yamauchi, Amane ^b   Sakamoto, Haruhiko ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

BP; IL 6; mRNA; TNF

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; PEMPHIGOID;

EID: 0029978594     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Lever WF. Pemphigus and pemphigoid. A review of the advances made since 1964. J Am Acad Dermatol 1979; 1: 2-31.
2. Naito K, Morioka S, Ogawa H. The pathogenic mechanisms of blister formation in bullous pemphigoid. J Invest Dermatol 1982; 79: 303-6.
3. Kaneko F, Minagawa T, Takiguchi Y, Suzuki M, Itoh N. Role of cell-mediated immune reaction in blister formation of bullous pemphigoid. Dermatology 1992; 184: 34-9.
4. Nestor MS, Cochran AJ, Ahmed AR. Mononuclear cell infiltrates in bullous disease. J Invest Dermatol 1987: 88: 172-5.
5. Diaz-Perez JL, Jordan RE. The complement system in bullous pemphigoid. IV. Chemotactic activity in blister fluid. Clin Immunol Immunopathol 1976; 5: 360-70.
6. Baba T, Sonozaki H, Seki K, Uchiyama M, Ikesawa Y, Torisu M. An eosinophilic chemotactic factor present in blister fluids of bullous pemphigoid patients. J Immunol 1976; 116: 112-6.
7. Center DM, Wintroub BU, Austen KF. Identification of chemoattractant activity for lymphocytes in blister fluid of patients with bullous pemphigoid: evidence for the presence of a lymphokine. J Invest Dermatol 1983; 81: 204-8.
8. Tamaki K, So K, Furuya T, Furue M. Cytokine profile of patients with bullous pemphigoid. Br J Dermatol 1994; 130: 128-9.
9. Groves RW, Allen MH, Ross EL, Barker JNWN, MacDonald DM. Tumor necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol 1995; 132: 34-52.
10. Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1-10.
11. Piguet PF, Grau GE, Hauser C, Vassalli P. Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivily reactions. J Exp AW 1991; 173: 673-9.
12. Piguet PF, Grau GE, Allet B, Vassalli P. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-versus-host disease. J Exp Med 1987; 166: 1280-9.
13. Luger TA, Schwarz T, Krutmann J, Kirnbauer R, Neuner P, Köck A, Urbanski A, Borth W, Schauer E. Interleukin-6 is produced by epidermal cells and plays an important role in the activation of human T-lymphocytes and natural killer cells. Ann NY Acad Sci 1989; 55: 405-14.
14. Howie SEM, Aldridge RD, McVittie E, Thornton E, Ramage E, Hunter JAA. A non-radiolabelled in situ hybridization method for the detection of epidermal cytokine mRNA. Exp Dermatol 1992; 1: 230-5.
15. Carswell EA, Old U, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72: 3666-70.
16. Köck A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansei JC, Luger TA. Human keratinocytes are a source for tumor necrosis factor α: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990; 172: 1609-14.
17. Grau GE, Lambert PH, Vassalli P, Piguet PF. Tumor necrosis facfor/cachectin as an effector of T cell-dependent immunopathology. Int Rev Exp Pahtol 1993; 348: 159-71.
18. Shabby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA Jr. Activation of human polymorphonuclear neutrophil functions by interferon-γ and tumor necrosis factors. J Immunol 1985; 135: 2069-73.
19. Lamas AM, Mulroney CM, Schleimer RP. Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells. J Immunol 1988; 140: 1500-5.
20. Lawlor F, Smith NP, Camp RDR, Bacon KB, Black AK, Greaves MV, Gearing AJH. Skin exudate levels of interleukin-6, interleukin-1 and other cytokines in mycosis fungoides. Br J Dermatol 1990; 123: 297-304.
21. Grossman RM, Krueger J, Yourish D et al, lnterleukin-6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 1989; 86: 6367-71.
22. Gammon WR, Merritt CC, Lewis DM, Sams WM Jr. Carlo JR, Wheeler CE Jr. An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement. J Invest Dermatol 1982, 78: 285-90.
23. Cumberbatch M, Kimber I. Dermal tumor necrosis factor-α induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology 1992, 75: 257-63.
24. Hunyadi J, Dobozy A, Kenderessy AS. Evidence for cell-mediated autoimmunily in patients with pemphigus vulgaris and bullous pemphigoid. Arch Dermatol Res 1979, 265: 9-14